DiscoverDrug Safety Matters#2 Why we should listen to patients – Linda Härmark
#2 Why we should listen to patients – Linda Härmark

#2 Why we should listen to patients – Linda Härmark

Update: 2020-05-20
Share

Description

As the end users of medicines, patients can provide first-hand information on side effects. The issues they report add a richness to our understanding of medicine safety that we could never achieve by relying on healthcare professionals’ reports alone – so it’s crucial that we listen to them. Linda Härmark from the Netherlands pharmacovigilance centre Lareb tells us more.

Tune in to find out:

  • What patient reports reveal about people’s use of medicines
  • How to make best use of the information relayed by patients
  • What to consider when setting up a patient reporting system

Want to know more?

Here are a few reading resources to get you started:

If you’d like to hear more from the Netherlands pharmacovigilance centre Lareb, check out this interview with Eugene van Puijenbroek on intuitive and clinical reasoning.

Join the conversation on social media
Follow us on Twitter, Facebook or LinkedIn, and share your thoughts about the show with the hashtag #DrugSafetyMatters.

Got a story to share?
We’re always looking for new content and interesting people to interview. If you have a great idea for a show, get in touch!

About UMC
Read more about Uppsala Monitoring Centre and how we work to make medicines safer for patients.

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

#2 Why we should listen to patients – Linda Härmark

#2 Why we should listen to patients – Linda Härmark

Uppsala Monitoring Centre